Shigella Infections
GSK Licenses Experimental Shigella Vaccine to Bharat Biotech for Development and Distribution
GSK; Bharat Biotech; Shigella vaccine; altSonflex1-2-3; vaccine licensing; Shigellosis; GMMA platform; antimicrobial resistance; low and middle-income countries